Assembly Biosciences (ASMB) Current Leases (2019 - 2026)
Assembly Biosciences' (ASMB) quarterly Current Leases came in at $590000.0 in Q1 2026, up 11.53% year-on-year from $529000.0 in Q1 2025, and up 3.69% quarter-over-quarter from $569000.0 in Q4 2025.
Assembly Biosciences (ASMB) Current Leases (2019 - 2026) Analysis & Trends
Assembly Biosciences' Current Leases history runs 8 years deep, the most recent figure standing at $590000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 11.53% year-over-year to $590000.0 in Q1 2026; TTM through Mar 2026 was $590000.0, a 11.53% increase from a year earlier, with the FY2025 full-year figure at $569000.0, up 23.43% from the prior year.
- Current Leases grew to $590000.0 in Q1 2026 per ASMB's latest filing, from $569000.0 in the prior quarter.
- Across five years, Current Leases topped out at $3.4 million in Q3 2022 and bottomed at $461000.0 in Q4 2024.
- The 5-year median for Current Leases is $1.2 million (2023), against an average of $1.6 million.
- Across the five-year window, Current Leases slumped 74.22% in 2023 and surged 52.93% in 2024, its largest moves.
- Year by year, Current Leases stood at $3.4 million in 2022, then tumbled by 63.73% to $1.2 million in 2023, then slumped by 62.21% to $461000.0 in 2024, then gained by 23.43% to $569000.0 in 2025, then rose by 3.69% to $590000.0 in 2026.
- Per Business Quant, the three latest ASMB Current Leases figures stand at $590000.0 (Q1 2026), $569000.0 (Q4 2025), and $548000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Assembly Biosciences | 431.63 Mn | 205.03 Mn | - | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 590,000.00 |
| Dec 31, 2025 | 569,000.00 |
| Sep 30, 2025 | 548,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Mar 31, 2025 | 529,000.00 |
| Dec 31, 2024 | 461,000.00 |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 869,000.00 |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 3.31 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 3.10 Mn |
| Jun 30, 2021 | 3.05 Mn |